Advancing the use of RWE with our research collaborators
Generate real-world evidence across the life cycle of a drug, pre- and post-launch
Flatiron real-world data has informed key clinical development decisions, supported clinical trial data in regulatory submissions, fulfilled post-marketing commitments, and enabled market access and payer decisions.
The world’s leading biopharma companies use Flatiron real-world data products to accelerate R&D and access, make research more inclusive, and drive transformative cancer care.
Our foundational data subscriptions, covering 22 tumor types, deliver a wide pool of clinical data sourced from electronic health records reflecting patients’ journeys from diagnosis onward.
Real-world Clinico-Genomic Database (CGDB) integrating clinical data curated from electronic health records with comprehensive genomic profiling data for patients in the Flatiron network who are tested with a Foundation Medicine assay.
Spotlight Custom Solutions
Spotlight projects provide fit-for-purpose data, building on our subscription offerings, and expertise tailored to answer our partners specific research questions.
Enhance data depth and longitudinality with integrated evidence, which thoughtfully combines real-world data from different sources. Flatiron can link patient-level EHR data with genomics, imaging or claims data.
Linked EHR and Genomics Data
Flatiron Health and Foundation Medicine’s Clinico-Genomics Database for disease-specific and disease-agnostic analyses.
Linked EHR and Radiology Imaging Data
Datasets that link radiology images (DICOM) with Flatiron’s EHR-derived clinical and outcomes data for disease-specific and disease-agnostic analyses.
Linked EHR and Claims Data
A real-world linked EHR-Claims data solution that is de-identified and ready for use, unlocking the full patient journey.